Morte A - Search Results

1

Noradrenergic stimulation enhances human action monitoring.

Riba J, Rodríguez-Fornells A, Morte A, Münte TF, Barbanoj MJ. Riba J, et al. Among authors: morte a. J Neurosci. 2005 Apr 27;25(17):4370-4. doi: 10.1523/JNEUROSCI.4437-04.2005. J Neurosci. 2005. PMID: 15858063 Free PMC article. Clinical Trial.

2

Topographic pharmaco-EEG mapping of the effects of the South American psychoactive beverage ayahuasca in healthy volunteers.

Riba J, Anderer P, Morte A, Urbano G, Jané F, Saletu B, Barbanoj MJ. Riba J, et al. Among authors: morte a. Br J Clin Pharmacol. 2002 Jun;53(6):613-28. doi: 10.1046/j.1365-2125.2002.01609.x. Br J Clin Pharmacol. 2002. PMID: 12047486 Free PMC article. Clinical Trial.

3

Human pharmacology of ayahuasca: subjective and cardiovascular effects, monoamine metabolite excretion, and pharmacokinetics.

Riba J, Valle M, Urbano G, Yritia M, Morte A, Barbanoj MJ. Riba J, et al. Among authors: morte a. J Pharmacol Exp Ther. 2003 Jul;306(1):73-83. doi: 10.1124/jpet.103.049882. Epub 2003 Mar 26. J Pharmacol Exp Ther. 2003. PMID: 12660312 Clinical Trial.

4

Central and peripheral evaluation of rupatadine, a new antihistamine/platelet-activating factor antagonist, at different doses in healthy volunteers.

Barbanoj MJ, García-Gea C, Morte A, Izquierdo I, Pérez I, Jané F. Barbanoj MJ, et al. Among authors: morte a. Neuropsychobiology. 2004;50(4):311-21. doi: 10.1159/000080959. Neuropsychobiology. 2004. PMID: 15539863 Clinical Trial.

5

Subjective effects and tolerability of the South American psychoactive beverage Ayahuasca in healthy volunteers.

Riba J, Rodríguez-Fornells A, Urbano G, Morte A, Antonijoan R, Montero M, Callaway JC, Barbanoj MJ. Riba J, et al. Among authors: morte a. Psychopharmacology (Berl). 2001 Feb;154(1):85-95. doi: 10.1007/s002130000606. Psychopharmacology (Berl). 2001. PMID: 11292011 Clinical Trial.

6

Differential effects of alprazolam on the baseline and fear-potentiated startle reflex in humans: a dose-response study.

Riba J, Rodríguez-Fornells A, Urbano G, Morte A, Antonijoan R, Barbanoj MJ. Riba J, et al. Among authors: morte a. Psychopharmacology (Berl). 2001 Oct;157(4):358-67. doi: 10.1007/s002130100816. Psychopharmacology (Berl). 2001. PMID: 11605094 Clinical Trial.

7

Basics of PK-PD using QEEG: acute/repetitive administration, interactions. Focus on anxiolytics with different neurochemical mechanisms as examples.

Barbanoj MJ, Riba J, Morte A, Antonijoan RM, Jané F. Barbanoj MJ, et al. Among authors: morte a. Methods Find Exp Clin Pharmacol. 2002;24 Suppl C:67-83. Methods Find Exp Clin Pharmacol. 2002. PMID: 12575490 Review.

8

A study comparing the inhibitory effects of single and repeated oral doses of ebastine and fexofenadine against histamine-induced skin reactivity.

Barbanoj MJ, Antonijoan RM, García-Gea C, Morte A, Gich I, Gispert J, Garcia E, Esbrí R, Luria X. Barbanoj MJ, et al. Among authors: morte a. Int Arch Allergy Immunol. 2003 Nov;132(3):263-7. doi: 10.1159/000074308. Int Arch Allergy Immunol. 2003. PMID: 14646388 Clinical Trial.

9

Effects of tobacco smoking on the kinetics of the pupillary light reflex: a comparison between smokers and non-smokers.

Morte A, Benito L, Grasa E, Clos S, Riba J, Barbanoj MJ. Morte A, et al. Neuropsychobiology. 2005;52(4):169-75. doi: 10.1159/000088859. Epub 2005 Oct 10. Neuropsychobiology. 2005. PMID: 16220022

10

No sex-related pharmacokinetic and pharmacodynamic differences of captopril.

Massana E, Barbanoj MJ, Moros C, Morte A, Gich I, Jané F. Massana E, et al. Among authors: morte a. Pharmacol Res. 1997 Jul;36(1):41-7. doi: 10.1006/phrs.1997.0202. Pharmacol Res. 1997. PMID: 9368913

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

90 results

Search Page

Filters